Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial

Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology across its content.
    Difference
    1%
    Check dated 2026-10-25T13:44:03.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:22:58.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:56:13.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the study content, with boilerplate HTML and a 403 title, indicating an access issue when attempting to view the study entry.
    Difference
    0.5%
    Check dated 2026-09-27T19:43:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Access to the study page now returns a 403 Forbidden error, replacing the expected study content and indicating restricted access to NCT03850535. The error page displays site chrome (header/footer) but no study details are visible.
    Difference
    23%
    Check dated 2026-09-20T20:47:45.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new NIH grant/contract funding note was added to the page, and the site revision was updated to v3.6.6 (replacing v3.6.5), reflecting funding attribution and a version bump.
    Difference
    0.1%
    Check dated 2026-08-30T06:27:20.000Z thumbnail image

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.